There is increasing evidence that showed upregulated TRIP13 levels play a role in some tumors, including head and neck cancer, breast cancer, lung cancer, liver cancer, prostate cancer, gastric cancer, and human chronic lymphoblastic leukemia [20, 21]. Here, TRIP13 is linked to head and neck cancer.